Literature DB >> 6749346

Enhanced renin levels after discontinuation of furosemide: additional effects of loop diuretics on renin release.

M L Tuck, M P Sambhi, S B Kramer, P Eggena, J Barrett.   

Abstract

The rate of recovery of the renin-angiotensin-aldosterone axis after stopping diuretic administration was examined in 18 male patients with essential hypertension. Upright plasma renin activity (PRA) and plasma aldosterone (PA) were measured during sodium restriction (10 mEq sodium intake), after three days of furosemide administration (40 mg BID po) and for five days following cessation of the diuretic. After diuretic administration, the mean PRA level (8.2 +/- 1.7 ng/ml/hr) was significantly elevated compared to the level on low sodium diet (4.2 +/- 0.5 ng/ml/hr). However, the major finding was that PRA levels continued to increase significantly compared to levels during diuresis on days 1 (11.3 +/- 1.7 ng/ml/hr) and 2 (10.8 +/- 1.5 ng/ml/hr) of the postdiuretic period. Mean PA values paralleled PRA responses in the study. Infusion of normal saline on postdiuretic day 1 failed to suppress PRA to levels seen in subjects not receiving diuretics. The postdiuretic period was accompanied by increased urinary sodium reabsorption and decreased urinary potassium excretion and by significant decreases in creatinine, PAH and free water clearance. The mechanism of this sustained renin response several days after cessation of diuretic therapy may be best explained by a prolonged action of furosemide or by partial ongoing volume depletion with reduced sodium load to the distal nephron. Since all patients demonstrated a marked and consistent PRA response after diuretic withdrawal, this time period represents a potent stimulatory challenge for monitering renin responses.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749346     DOI: 10.3109/10641968209060795

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  2 in total

1.  An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.

Authors:  Jennifer S Hanberg; W H Wilson Tang; F Perry Wilson; Steven G Coca; Tariq Ahmad; Meredith A Brisco; Jeffrey M Testani
Journal:  Int J Cardiol       Date:  2017-03-27       Impact factor: 4.164

2.  Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man.

Authors:  R J MacFadyen; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.